5-126402275-A-G
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001146319.3(GRAMD2B):c.128+41816A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.958 in 152,188 control chromosomes in the GnomAD database, including 69,843 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001146319.3 intron
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001146319.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GRAMD2B | NM_001146319.3 | c.128+41816A>G | intron | N/A | NP_001139791.1 | Q96HH9-3 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GRAMD2B | ENST00000513040.5 | TSL:2 | c.128+41816A>G | intron | N/A | ENSP00000426120.1 | Q96HH9-3 | ||
| GRAMD2B | ENST00000506445.5 | TSL:5 | c.125+30708A>G | intron | N/A | ENSP00000424985.1 | D6REP5 | ||
| ENSG00000250602 | ENST00000648070.1 | n.896-8645T>C | intron | N/A |
Frequencies
GnomAD3 genomes AF: 0.958 AC: 145682AN: 152070Hom.: 69791 Cov.: 32 show subpopulations
GnomAD4 genome AF: 0.958 AC: 145793AN: 152188Hom.: 69843 Cov.: 32 AF XY: 0.959 AC XY: 71388AN XY: 74424 show subpopulations
Age Distribution
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at